A Phase I Clinical Study of a Single Dose of KLA480

Clinical trial NCT07030790 · RECRUITING

Trial details

NCT number: NCT07030790
Sponsor: Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2025-05-17
Primary completion: 2026-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.